Home » Topics » BioWorld Science

BioWorld Science
RSS

Natural killer cell phenotype GAIA-102 has antitumor activity

May 31, 2018

Treeway completes phase I study of oral formulation of TW-001 for ALS

May 31, 2018

Denali Therapeutics exercises option to acquire F-star Gamma

May 31, 2018

Arix, Evotec and Fred Hutchinson establish academic bridge collaboration

May 31, 2018

FDA grants priority review to Fycompa pediatric sNDA

May 31, 2018

GlycoMimetics enters agreement with NCI for pivotal study of uproleselan in AML

May 31, 2018

FDA approves Xeljanz for moderate to severely active ulcerative colitis

May 31, 2018

GSK, Cloud Pharmaceuticals form drug discovery collaboration

May 31, 2018

Zai Lab and Crescendo enter licensing agreement for antibody VH domain therapeutic

May 31, 2018

Researchers develop early-metastatic RCC model in chickens

May 31, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...